All-Atom
Contacts
Clashscore, all atoms:1.94 100th percentile* (N=456, 2.20Å ± 0.25Å)
Clashscore is the number of serious steric overlaps (> 0.4 Å) per 1000 atoms.
Protein
Geometry
Poor rotamers82.59% Goal: <1%
Ramachandran outliers20.58% Goal: <0.05%
Ramachandran favored32895.91% Goal: >98%
MolProbity score^1.5698th percentile* (N=10167, 2.20Å ± 0.25Å)
Cβ deviations >0.25Å00.00% Goal: 0
Bad backbone bonds:0 / 13890.00% Goal: 0%
Bad backbone angles:0 / 17310.00% Goal: <0.1%
In the two column results, the left column gives the raw count, right column gives the percentage.
* 100th percentile is the best among structures of comparable resolution; 0th percentile is the worst. For clashscore the comparative set of structures was selected in 2004, for MolProbity score in 2006.
^ MolProbity score combines the clashscore, rotamer, and Ramachandran evaluations into a single score, normalized to be on the same scale as X-ray resolution.

Live sorting requires JavaScript enabled and Safari 2, Firefox 1.5, or IE 6

#ResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengths.Bond angles.
Avg: 60.32Clashscore: 1.94Outliers: 2 of 342Poor rotamers: 8 of 309Outliers: 0 of 334Outliers: 0 of 348Outliers: 0 of 348
A 45 ASP87.19--0.3%
chi angles: 226.6,77.6
0.076Å--
A 46 ASN101.9-Favored (33.38%)
General case / -59.0,-18.3
48.2% (t30)
chi angles: 182.4,42
0.024Å--
A 47 GLN68.8-Favored (61.52%)
General case / -72.7,-18.6
25.6% (mt-30)
chi angles: 290.8,172.1,136.8
0.033Å--
A 48 PHE48.91-Favored (19.02%)
General case / -112.1,158.9
78.5% (m-85)
chi angles: 301.3,85.2
0.022Å--
A 49 TYR49.37-Favored (36.17%)
General case / -143.6,148.6
10.1% (p90)
chi angles: 81.5,103.3
0.118Å--
A 50 SER57.59-Favored (39.47%)
General case / -101.7,137.8
42.7% (m)
chi angles: 288.8
0.059Å--
A 51 VAL61.78-Favored (52.44%)
Isoleucine or valine / -128.2,139.2
0%
chi angles: 260
0.185Å--
A 52 GLU111.89-Favored (20.29%)
General case / -80.4,116.1
14.5% (tp10)
chi angles: 202.2,58.7,50.3
0.042Å--
A 53 VAL69.930.647Å
HG13 with A 69 PRO HG3
Allowed (1.26%)
Isoleucine or valine / -121.8,88.4
78.1% (t)
chi angles: 172.4
0.159Å--
A 54 GLY76.94-Favored (2.98%)
Glycine / 67.0,-109.6
----
A 55 ASP96.92-Favored (18.51%)
General case / -98.9,-17.1
9.2% (p-10)
chi angles: 60.8,108.7
0.039Å--
A 56 SER79.32-Favored (17.57%)
General case / -95.3,153.7
8.5% (t)
chi angles: 194.1
0.007Å--
A 57 THR63.21-Favored (50.82%)
General case / -107.3,125.2
44.1% (m)
chi angles: 305.4
0.106Å--
A 58 PHE44.33-Favored (25.35%)
General case / -99.7,113.1
2.9% (m-85)
chi angles: 262.4,63.7
0.027Å--
A 59 THR44.41-Favored (8.59%)
General case / -105.8,99.0
42.4% (m)
chi angles: 305.5
0.136Å--
A 60 VAL42.32-Favored (15.18%)
Isoleucine or valine / -118.8,164.3
22.4% (m)
chi angles: 302.8
0.105Å--
A 61 LEU42.81-Favored (58.82%)
General case / -63.6,139.9
43.9% (mt)
chi angles: 287.9,161.8
0.083Å--
A 62 LYS56.41-Favored (28.72%)
General case / -58.8,-18.0
84.9% (mttt)
chi angles: 285.7,167.9,167.2,174.6
0.122Å--
A 63 ARG49.32-Favored (67.27%)
General case / -63.1,-23.1
16.8% (ptm180)
chi angles: 67.1,182.9,287.1,172.9
0.018Å--
A 64 TYR43.73-Favored (27.55%)
General case / -96.9,115.5
51.4% (m-85)
chi angles: 304.2,116.9
0.039Å--
A 65 GLN79.32-Favored (28.65%)
General case / -122.4,158.9
30.5% (mt-30)
chi angles: 288.8,149.6,32.4
0.051Å--
A 66 ASN75.24-Favored (11.56%)
General case / 54.2,53.1
3.7% (t-20)
chi angles: 193.5,216.4
0.085Å--
A 67 LEU46.44-Favored (42.21%)
General case / -61.5,129.7
5.8% (mp)
chi angles: 265.3,74.4
0.122Å--
A 68 LYS112.15-Favored (17.01%)
Pre-proline / -133.2,122.0
79.3% (mttt)
chi angles: 296.1,198.4,171.8,190
0.052Å--
A 69 PRO53.160.647Å
HG3 with A 53 VAL HG13
Favored (78.54%)
Trans proline / -59.3,137.4
22.6% (Cg_exo)
chi angles: 343.8,28.1,91.9
0.035Å--
A 70 ILE44.65-Favored (4.13%)
Isoleucine or valine / -127.3,-2.2
41.3% (pt)
chi angles: 57.1,169.9
0.16Å--
A 71 GLY43.94-Favored (8.7%)
Glycine / 151.1,159.2
----
A 72 SER52.59-Favored (35.28%)
General case / -144.1,162.8
77.6% (p)
chi angles: 58.7
0.01Å--
A 73 GLY47.45-Favored (19.62%)
Glycine / -151.1,-171.9
----
A 74 ALA52.9-Favored (72.95%)
General case / -62.5,-32.1
-0.017Å--
A 75 GLN60.3-Favored (35.33%)
General case / -80.1,-36.5
2.4% (tt0)
chi angles: 212,213.6,0.3
0.05Å--
A 76 GLY48.69-Favored (47.19%)
Glycine / 177.7,178.4
----
A 77 ILE60.07-Favored (24.74%)
Isoleucine or valine / -100.6,138.5
13.4% (mm)
chi angles: 317.1,298.5
0.031Å--
A 78 VAL36.53-Favored (64.51%)
Isoleucine or valine / -120.1,134.2
19.6% (t)
chi angles: 189
0.105Å--
A 79 CYS44.4-Favored (36.44%)
General case / -120.8,154.0
50.7% (m)
chi angles: 283.6
0.019Å--
A 80 ALA40.11-Favored (22.15%)
General case / -97.3,149.3
-0.136Å--
A 81 ALA40.14-Favored (37.05%)
General case / -158.8,161.8
-0.058Å--
A 82 TYR58.33-Favored (43.39%)
General case / -99.7,122.9
42.1% (t80)
chi angles: 171.7,62.2
0.052Å--
A 83 ASP44.31-Favored (16.57%)
General case / -91.7,104.1
61.1% (t0)
chi angles: 178.6,173.8
0.029Å--
A 84 ALA50.72-Favored (67.35%)
General case / -64.3,-23.6
-0.039Å--
A 85 VAL52.54-Favored (32.69%)
Isoleucine or valine / -75.9,-47.3
46% (t)
chi angles: 168
0.124Å--
A 86 LEU51.37-Favored (38.33%)
General case / -86.5,-16.0
82.1% (mt)
chi angles: 289.4,174.7
0.08Å--
A 87 ASP74.56-Favored (10.32%)
General case / 58.7,49.4
21.8% (t0)
chi angles: 181.1,42.1
0.076Å--
A 88 ARG96.04-Favored (34.08%)
General case / -144.0,147.6
0.4%
chi angles: 233.3,181.6,147.8,166.3
0.213Å--
A 89 ASN60.02-Favored (32.81%)
General case / -84.5,138.4
83.3% (m-20)
chi angles: 294.2,311
0.026Å--
A 90 VAL36.76-Favored (32.41%)
Isoleucine or valine / -128.3,163.5
35.5% (m)
chi angles: 297.9
0.073Å--
A 91 ALA35.69-Favored (55.14%)
General case / -111.3,131.4
-0.089Å--
A 92 ILE41.82-Favored (63.26%)
Isoleucine or valine / -119.2,120.2
53.1% (mt)
chi angles: 307.6,171.6
0.059Å--
A 93 LYS47.15-Favored (53.28%)
General case / -105.0,128.6
37.2% (ttpt)
chi angles: 178,163.1,72.7,175.8
0.017Å--
A 94 LYS45.98-Favored (46.68%)
General case / -100.8,129.3
79% (tttt)
chi angles: 181.4,193.5,180,185.8
0.025Å--
A 95 LEU37.75-Favored (20.82%)
General case / -109.0,109.7
79.9% (mt)
chi angles: 302.9,179.8
0.042Å--
A 96 SER58.96-Favored (26.63%)
General case / -89.2,115.3
10.3% (m)
chi angles: 311.3
0.044Å--
A 97 ARG56.52-Favored (9.44%)
Pre-proline / 43.7,62.3
72% (mtp85)
chi angles: 302.1,184.1,67,82.2
0.07Å--
A 98 PRO39.32-Favored (60.56%)
Trans proline / -60.1,-20.2
39.2% (Cg_endo)
chi angles: 23.6,323.2,155
0.057Å--
A 99 PHE44.43-Favored (31.56%)
General case / -81.1,1.4
21.8% (p90)
chi angles: 49.4,80.8
0.015Å--
A 100 GLN55.63-Favored (66.92%)
General case / -56.8,-33.7
9.5% (pt20)
chi angles: 67.5,186.7,265.9
0.135Å--
A 101 ASN53.05-Favored (35.58%)
General case / -150.2,164.5
22.3% (p30)
chi angles: 63.2,62.8
0.117Å--
A 102 GLN90.89-Favored (68.73%)
General case / -53.9,-42.4
2.8% (tp-100)
chi angles: 209.7,81.2,211.6
0.015Å--
A 103 THR61.68-Favored (55.01%)
General case / -65.1,-52.5
16% (m)
chi angles: 311.6
0.128Å--
A 104 HIS56.22-Favored (91.88%)
General case / -65.8,-40.2
56% (m-70)
chi angles: 285.7,308.4
0.037Å--
A 105 ALA43.95-Favored (60.91%)
General case / -65.2,-51.5
-0.071Å--
A 106 LYS105.89-Favored (78.85%)
General case / -56.9,-48.2
20.1% (tptm)
chi angles: 186.4,83.3,178,285.5
0.022Å--
A 107 ARG67.5-Favored (73.57%)
General case / -61.2,-50.3
60.4% (ttt180)
chi angles: 188.3,183,162.9,172.7
0.103Å--
A 108 ALA40.59-Favored (96.61%)
General case / -60.6,-42.4
-0.025Å--
A 109 TYR68.92-Favored (48.99%)
General case / -67.4,-51.7
91.7% (t80)
chi angles: 179.2,78.2
0.095Å--
A 110 ARG83.570.532Å
CZ with A 211 ALA HB2
Favored (85.34%)
General case / -58.4,-41.7
36.7% (ttt-85)
chi angles: 191.1,174.7,158.5,257.2
0.078Å--
A 111 GLU66.87-Favored (67.3%)
General case / -61.7,-51.7
79.6% (mt-10)
chi angles: 279.1,178.7,163.6
0.036Å--
A 112 LEU53.41-Favored (67.5%)
General case / -53.7,-49.7
18.9% (mt)
chi angles: 276.1,167.7
0.023Å--
A 113 VAL54.78-Favored (73.67%)
Isoleucine or valine / -65.1,-50.5
43.9% (t)
chi angles: 167.6
0.119Å--
A 114 LEU56.39-Favored (85.16%)
General case / -64.9,-36.7
71% (mt)
chi angles: 292.2,181.1
0.146Å--
A 115 MET63.2-Favored (4.13%)
General case / -57.5,-13.8
43.5% (mtm)
chi angles: 279.3,178.3,303.3
0.105Å--
A 116 LYS109.67-Favored (13.6%)
General case / -103.2,-24.1
92.7% (mttt)
chi angles: 296.1,167.9,181.6,180.3
0.021Å--
A 117 CYS77.84-Favored (28.39%)
General case / -89.0,8.7
95.2% (m)
chi angles: 293.9
0.073Å--
A 118 VAL63.050.456Å
HA with A 373 PRO HG2
Favored (34.97%)
Isoleucine or valine / -131.6,145.5
29.4% (m)
chi angles: 295.1
0.177Å--
A 119 ASN77.17-Allowed (1.63%)
General case / -146.2,83.5
43.9% (t30)
chi angles: 180.9,41.3
0.078Å--
A 120 HIS47.32-Favored (16.96%)
General case / -153.1,137.8
50.7% (t-80)
chi angles: 196.9,277.1
0.032Å--
A 121 LYS83.2-Favored (63.96%)
General case / -67.4,-15.9
57.6% (pttt)
chi angles: 63.2,178.2,171.4,187.9
0.127Å--
A 122 ASN41.44-Favored (51.05%)
General case / -96.9,5.2
29.9% (m120)
chi angles: 301.2,126.4
0.131Å--
A 123 ILE36.99-Favored (50.19%)
Isoleucine or valine / -122.8,139.3
50.9% (mm)
chi angles: 302.6,299.3
0.031Å--
A 124 ILE51.79-Allowed (0.77%)
Isoleucine or valine / -43.1,137.4
7.7% (tt)
chi angles: 181.9,183.2
0.066Å--
A 125 SER61.8-Favored (41.74%)
General case / -132.3,131.2
35.1% (t)
chi angles: 182.9
0.096Å--
A 126 LEU42.33-Favored (33.31%)
General case / -84.0,138.0
16.4% (mt)
chi angles: 286.5,191.8
0.055Å--
A 127 LEU44.11-Favored (14.17%)
General case / -90.8,-36.5
0%
chi angles: 256.2,16.9
0.129Å--
A 128 ASN46.24-Favored (33.68%)
General case / -159.3,159.1
11.1% (t-20)
chi angles: 210.6,351.5
0.05Å--
A 129 VAL42.38-Favored (10.57%)
Isoleucine or valine / -146.2,130.2
2.4% (p)
chi angles: 48.1
0.143Å--
A 130 PHE38.04-Favored (41.52%)
General case / -154.4,161.8
53.1% (p90)
chi angles: 64.5,90
0.056Å--
A 131 THR41.8-Favored (23.34%)
Pre-proline / -131.2,131.8
6.9% (t)
chi angles: 178.3
0.143Å--
A 132 PRO49.1-Favored (37.05%)
Trans proline / -69.0,-21.4
4.4% (Cg_exo)
chi angles: 355.7,20.3,92.4
0.051Å--
A 133 GLN53.01-Favored (38.91%)
General case / -77.2,133.5
13.8% (mp0)
chi angles: 295.2,94.4,39.7
0.12Å--
A 134 LYS111.47-Favored (33.69%)
General case / -81.8,-27.5
87.4% (mttt)
chi angles: 298.2,170.3,192.5,176.2
0.028Å--
A 135 THR63.11-Favored (34.78%)
General case / -131.1,160.4
58.9% (p)
chi angles: 56.4
0.052Å--
A 136 LEU66.36-Favored (81.78%)
General case / -59.5,-38.8
47.2% (tp)
chi angles: 170.8,63.3
0.024Å--
A 137 GLU102.75-Favored (96.89%)
General case / -64.3,-40.9
1.9% (tp10)
chi angles: 226.5,50.4,52.6
0.096Å--
A 138 GLU83.69-Favored (45.51%)
General case / -81.9,-17.9
48.4% (mt-10)
chi angles: 293.2,175.3,100.4
0.043Å--
A 139 PHE45.45-Favored (7.21%)
General case / -48.8,123.6
40.6% (t80)
chi angles: 176.6,57.9
0.1Å--
A 140 GLN78.55-Allowed (0.95%)
General case / -132.6,-54.5
33.3% (mt-30)
chi angles: 291.1,205.2,70.6
0.028Å--
A 141 ASP45.36-Favored (37.74%)
General case / -115.2,149.4
14.7% (m-20)
chi angles: 313.6,126.3
0.03Å--
A 142 VAL36.99-Favored (72.5%)
Isoleucine or valine / -120.7,131.6
91.8% (t)
chi angles: 175.5
0.013Å--
A 143 TYR40.34-Favored (56.63%)
General case / -114.2,129.7
77.8% (m-85)
chi angles: 294.5,80.8
0.011Å--
A 144 LEU37.69-Favored (51.09%)
General case / -114.7,138.1
62% (mt)
chi angles: 304.5,173.4
0.033Å--
A 145 VAL34.24-Favored (66.13%)
Isoleucine or valine / -122.7,134.4
34% (t)
chi angles: 185.9
0.07Å--
A 146 MET34.59-Favored (13.51%)
General case / -141.7,171.8
27.7% (ptm)
chi angles: 69.9,174.4,284.8
0.014Å--
A 147 GLU66.49-Favored (54.19%)
General case / -56.4,134.9
15.1% (tt0)
chi angles: 202.6,198.9,140.1
0.182Å--
A 148 LEU39.19-Favored (22.43%)
General case / -72.6,123.0
54.1% (tp)
chi angles: 179.8,66.8
0.04Å--
A 149 MET41.58-Favored (14.32%)
General case / -95.7,160.8
76.9% (mmm)
chi angles: 306.9,290.7,279.5
0.129Å--
A 150 ASP49.14-Favored (22.17%)
General case / -85.3,-33.3
73.5% (m-20)
chi angles: 296.9,135.4
0.049Å--
A 151 ALA37.41-Favored (37.88%)
General case / -156.6,164.7
-0.056Å--
A 152 ASN48.33-Favored (7.08%)
General case / -97.2,173.7
49.3% (p30)
chi angles: 62.6,21.8
0.115Å--
A 153 LEU38.69-Favored (60.82%)
General case / -73.1,-21.0
13% (tp)
chi angles: 203,57
0.096Å--
A 154 CYS42.69-Favored (80.05%)
General case / -59.8,-48.9
93% (m)
chi angles: 293.6
0.019Å--
A 155 GLN60.21-Favored (98.52%)
General case / -61.0,-43.7
75.7% (mt-30)
chi angles: 294.1,171.2,289.4
0.053Å--
A 156 VAL46.130.418Å
O with A 159 MET HG2
Favored (83.22%)
Isoleucine or valine / -61.9,-39.3
48.6% (t)
chi angles: 168.4
0.128Å--
A 157 ILE41.23-Favored (65.54%)
Isoleucine or valine / -59.4,-36.7
5.9% (mt)
chi angles: 273.2,159.6
0.098Å--
A 158 GLN82.13-Favored (48.49%)
General case / -71.4,-7.6
66.3% (mt-30)
chi angles: 290.4,178.7,277.3
0.023Å--
A 159 MET56.230.418Å
HG2 with A 156 VAL O
Favored (18.9%)
General case / -112.6,159.4
19.3% (ptp)
chi angles: 63,194.7,70.6
0.144Å--
A 160 GLU61.82-Favored (31.71%)
General case / -81.5,126.5
46.3% (mt-10)
chi angles: 272.2,183.6,7.8
0.115Å--
A 161 LEU49.28-Favored (34.8%)
General case / -112.4,148.2
17% (mt)
chi angles: 298.1,157.2
0.071Å--
A 162 ASP70.6-Favored (12.03%)
General case / -79.6,174.0
11.4% (p-10)
chi angles: 59.2,117.6
0.055Å--
A 163 HIS46.69-Favored (70.54%)
General case / -69.3,-31.8
95.5% (m-70)
chi angles: 292.1,287.4
0.08Å--
A 164 GLU86.81-Favored (70.76%)
General case / -62.5,-50.6
14.6% (tt0)
chi angles: 178.2,202.6,89.7
0.021Å--
A 165 ARG93.42-Favored (66.53%)
General case / -69.5,-46.5
83% (mtt85)
chi angles: 288.3,180.4,181.7,88
0.086Å--
A 166 MET54.89-Favored (81.83%)
General case / -60.9,-48.4
49.1% (ttm)
chi angles: 194.4,184.2,288.7
0.13Å--
A 167 SER38.59-Favored (90.55%)
General case / -64.8,-38.3
83.3% (p)
chi angles: 69
0.083Å--
A 168 TYR48.03-Favored (96.62%)
General case / -64.0,-43.1
28.2% (t80)
chi angles: 184.2,52.4
0.07Å--
A 169 LEU38.12-Favored (98.24%)
General case / -61.2,-42.3
72.9% (mt)
chi angles: 294.6,166.7
0.056Å--
A 170 LEU35.12-Favored (83.08%)
General case / -67.6,-42.1
36.9% (mt)
chi angles: 292.2,160.2
0.05Å--
A 171 TYR53.35-Favored (79.4%)
General case / -56.1,-45.0
44.3% (t80)
chi angles: 165.5,74.4
0.013Å--
A 172 GLN45.59-Favored (85.74%)
General case / -67.4,-40.1
43.8% (mt-30)
chi angles: 289.3,174.9,94.6
0.067Å--
A 173 MET40.28-Favored (92.23%)
General case / -60.6,-45.9
14.5% (mtt)
chi angles: 290.1,175.4,235.5
0.033Å--
A 174 LEU36.89-Favored (87.51%)
General case / -62.9,-37.6
37.2% (mt)
chi angles: 293.9,160.9
0.115Å--
A 175 CYS42.73-Favored (78.73%)
General case / -63.4,-48.2
58.1% (m)
chi angles: 285.5
0.011Å--
A 176 GLY37.83-Favored (43.87%)
Glycine / -56.0,-53.2
----
A 177 ILE40.39-Favored (89.36%)
Isoleucine or valine / -59.5,-47.9
17.4% (mt)
chi angles: 292.6,148.6
0.079Å--
A 178 LYS73.28-Favored (72.27%)
General case / -54.8,-42.9
27.7% (tptt)
chi angles: 166,87.8,165.3,161.3
0.034Å--
A 179 HIS47.4-Favored (97.17%)
General case / -61.8,-44.3
62.4% (t60)
chi angles: 193.7,70
0.047Å--
A 180 LEU43.78-Favored (91.08%)
General case / -60.8,-46.3
72.9% (mt)
chi angles: 294.5,182.3
0.066Å--
A 181 HIS47.78-Favored (86.06%)
General case / -59.7,-39.9
55.6% (m170)
chi angles: 291.7,176.6
0.054Å--
A 182 SER56.1-Favored (67.7%)
General case / -65.1,-25.2
60.6% (p)
chi angles: 72.3
0.064Å--
A 183 ALA54.92-Favored (45.34%)
General case / -97.2,8.1
-0.024Å--
A 184 GLY49.41-Favored (83.1%)
Glycine / 79.9,12.7
----
A 185 ILE51.18-Favored (30.39%)
Isoleucine or valine / -94.9,114.0
14% (mt)
chi angles: 302.9,148.7
0.11Å--
A 186 ILE49.78-Favored (30.04%)
Isoleucine or valine / -110.1,109.9
49.5% (mt)
chi angles: 299.8,158.8
0.173Å--
A 187 HIS36.67-Allowed (0.2%)
General case / -55.0,-68.3
40.6% (t-80)
chi angles: 202,290.5
0.107Å--
A 188 ARG73.950.403Å
HG2 with A 244 VAL HG11
Favored (2.08%)
General case / 75.5,-5.9
62.5% (mtm180)
chi angles: 289.9,194.3,290.3,158
0.137Å--
A 189 ASP51.48-Favored (2.39%)
General case / -137.9,34.6
31.9% (t0)
chi angles: 199.5,17
0.103Å--
A 190 LEU38.67-Favored (57.57%)
General case / -62.3,135.7
22.3% (mt)
chi angles: 282.5,159.1
0.115Å--
A 191 LYS70.1-Favored (30.73%)
Pre-proline / -150.2,151.0
9.3% (ptpt)
chi angles: 65.9,191.4,94.5,183.6
0.088Å--
A 192 PRO34.75-Favored (67.5%)
Trans proline / -63.9,-25.8
18.1% (Cg_endo)
chi angles: 18.6,331.9,146.3
0.093Å--
A 193 SER38.66-Favored (65.53%)
General case / -67.5,-20.7
91.5% (p)
chi angles: 62.8
0.02Å--
A 194 ASN43.6-Favored (19.02%)
General case / -102.4,19.3
71.9% (m-20)
chi angles: 281,322.1
0.098Å--
A 195 ILE33.34-Favored (68.28%)
Isoleucine or valine / -128.6,128.7
35% (mt)
chi angles: 303.5,158.4
0.064Å--
A 196 VAL33.42-Favored (24.77%)
Isoleucine or valine / -121.2,153.2
4.2% (m)
chi angles: 284
0.15Å--
A 197 VAL38.89-Favored (43.04%)
Isoleucine or valine / -133.4,158.8
10.9% (m)
chi angles: 308
0.078Å--
A 198 LYS91.87-Favored (14.49%)
General case / -110.0,162.5
35.9% (mtmt)
chi angles: 273.2,202.9,286.7,186.8
0.055Å--
A 199 SER66.42-Favored (27.93%)
General case / -55.2,-24.7
74.7% (m)
chi angles: 294.2
0.015Å--
A 200 ASP58.23-Favored (19.54%)
General case / -86.1,8.7
48.1% (p-10)
chi angles: 67.5,172.8
0.075Å--
A 201 CYS55.29-Favored (3.51%)
General case / 76.0,8.6
0.6%
chi angles: 215.7
0.113Å--
A 202 THR51.45-Favored (39.64%)
General case / -77.2,142.2
58.2% (p)
chi angles: 62.5
0.147Å--
A 203 LEU34.45-Favored (50.59%)
General case / -128.1,148.9
8% (tt)
chi angles: 175.9,151
0.116Å--
A 204 LYS45.78-Favored (37.46%)
General case / -138.5,137.8
63.3% (mttm)
chi angles: 297.3,185.9,193.5,290.7
0.027Å--
A 205 ILE34.7-Favored (42.28%)
Isoleucine or valine / -89.3,126.4
87.8% (mt)
chi angles: 298.9,174
0.093Å--
A 206 LEU34.01-Favored (30.69%)
General case / -84.2,-23.0
44.7% (mt)
chi angles: 301.4,166.7
0.05Å--
A 207 ASP42.64-Favored (8.98%)
General case / -127.7,174.6
5.3% (p-10)
chi angles: 77,138.1
0.043Å--
A 208 PHE40.81-Favored (14.74%)
General case / -116.0,9.1
98.4% (m-85)
chi angles: 297.2,91.5
0.095Å--
A 209 GLY44.64-Favored (31.22%)
Glycine / 80.4,-150.0
----
A 210 LEU61.08-Favored (16.24%)
General case / -84.8,-41.2
74.8% (mt)
chi angles: 302,173.3
0.059Å--
A 211 ALA68.710.532Å
HB2 with A 110 ARG CZ
Allowed (0.2%)
General case / 65.3,169.2
-0.066Å--
A 212 ARG141.77---0.036Å--
A 217 SER103.93--76.1% (p)
chi angles: 58.4
0.052Å--
A 218 PHE98.93-Favored (31.57%)
General case / -95.5,139.6
46.9% (t80)
chi angles: 166,74.9
0.05Å--
A 219 MET96.45-Favored (43.97%)
General case / -133.1,134.3
19.1% (ttm)
chi angles: 212.4,179,279
0.035Å--
A 220 MET109.53-Favored (23.43%)
General case / -83.0,5.1
4.1% (mmt)
chi angles: 269,280.9,192.9
0.032Å--
A 221 THR103.55-Favored (60.73%)
Pre-proline / -84.9,156.8
82.7% (p)
chi angles: 60.6
0.08Å--
A 222 PRO104.91-Favored (9.09%)
Trans proline / -82.0,1.6
7.6% (Cg_endo)
chi angles: 9.9,7.6,98.1
0.052Å--
A 223 TYR102.19-Favored (56.17%)
General case / -67.5,137.9
64% (m-85)
chi angles: 284.4,86.7
0.02Å--
A 224 VAL88.93-Favored (64.64%)
Isoleucine or valine / -110.2,129.7
19% (t)
chi angles: 189.1
0.127Å--
A 225 VAL72.07-Favored (36.97%)
Isoleucine or valine / -75.8,129.5
48.5% (t)
chi angles: 182.7
0.135Å--
A 226 THR54.64-Favored (10.96%)
General case / -71.9,115.3
91.2% (m)
chi angles: 300.6
0.107Å--
A 227 ARG102.99-Favored (15.9%)
General case / -109.1,-5.8
73.4% (mtt85)
chi angles: 289,177.3,191.1,92.4
0.043Å--
A 228 TYR61.32-Favored (2.26%)
General case / -47.0,-29.8
7.1% (m-85)
chi angles: 314.9,135.3
0.065Å--
A 229 TYR37-Favored (29.6%)
General case / -103.1,-1.2
28.4% (m-85)
chi angles: 311.2,88.8
0.055Å--
A 230 ARG57.63-Favored (44.37%)
General case / -73.4,136.3
90.6% (mtt180)
chi angles: 283.2,174,194.8,182.1
0.118Å--
A 231 ALA41.87-Favored (98.05%)
Pre-proline / -67.2,150.2
-0.026Å--
A 232 PRO49.02-Favored (73.95%)
Trans proline / -52.5,-39.6
73.8% (Cg_exo)
chi angles: 332.9,38.2,86.5
0.021Å--
A 233 GLU56.4-Favored (66.46%)
General case / -65.8,-21.0
13.5% (pm0)
chi angles: 60.6,268.2,42.2
0.162Å--
A 234 VAL52.37-Favored (17.05%)
Isoleucine or valine / -85.0,-43.5
79.1% (t)
chi angles: 174.4
0.114Å--
A 235 ILE60.86-Favored (84.4%)
Isoleucine or valine / -60.5,-40.5
46.9% (mt)
chi angles: 294.9,156.3
0.046Å--
A 236 LEU58.78-Favored (45.11%)
General case / -98.5,8.3
50.6% (mt)
chi angles: 306.7,173.7
0.081Å--
A 237 GLY60.53-Favored (93.36%)
Glycine / 57.4,45.1
----
A 238 MET69.510.478Å
HB2 with A 238 MET HE2
Favored (6.09%)
General case / -97.5,175.8
16.5% (ttm)
chi angles: 206.3,178.5,314.8
0.225Å--
A 239 GLY54.46-Favored (54.69%)
Glycine / -73.8,163.6
----
A 240 TYR54.34-Favored (43.68%)
General case / -143.3,154.4
54.1% (p90)
chi angles: 63.4,88.6
0.033Å--
A 241 LYS76.03-Favored (2.62%)
General case / -122.2,-173.2
54.3% (pttt)
chi angles: 62.5,182.9,173.9,168.1
0.132Å--
A 242 GLU72.45-Favored (61.08%)
General case / -51.1,-43.1
43.1% (mp0)
chi angles: 282.3,82.3,171.8
0.057Å--
A 243 ASN45.23-Allowed (1.66%)
General case / -68.3,3.6
37.9% (p-10)
chi angles: 73.5,355.1
0.161Å--
A 244 VAL40.270.403Å
HG11 with A 188 ARG HG2
Favored (51.76%)
Isoleucine or valine / -58.6,-34.6
9% (p)
chi angles: 73
0.078Å--
A 245 ASP38.48-Favored (61.45%)
General case / -72.1,-24.1
74% (m-20)
chi angles: 289.4,143.5
0.101Å--
A 246 ILE36.770.498Å
HD11 with A 350 VAL HA
Favored (75.5%)
Isoleucine or valine / -65.5,-35.5
11.5% (mm)
chi angles: 285.1,287.8
0.133Å--
A 247 TRP34.5-Favored (92.66%)
General case / -60.9,-45.9
36.7% (t-105)
chi angles: 173.7,272.6
0.033Å--
A 248 SER35.21-Favored (93.42%)
General case / -62.5,-39.4
28.6% (m)
chi angles: 304.2
0.018Å--
A 249 VAL32.81-Favored (89.92%)
Isoleucine or valine / -64.6,-40.7
81.3% (t)
chi angles: 174.6
0.091Å--
A 250 GLY31.7-Favored (93.98%)
Glycine / -58.9,-46.2
----
A 251 CYS33-Favored (95.51%)
General case / -60.1,-43.4
90.7% (m)
chi angles: 291.7
0.005Å--
A 252 ILE35.37-Favored (75.95%)
Isoleucine or valine / -66.0,-49.6
73.5% (mt)
chi angles: 290.8,163.6
0.129Å--
A 253 MET40.37-Favored (88.28%)
General case / -59.1,-46.4
25.1% (ttt)
chi angles: 178.3,177.6,186.7
0.023Å--
A 254 GLY40.06-Favored (94.88%)
Glycine / -58.1,-42.1
----
A 255 GLU51.47-Favored (73.54%)
General case / -69.5,-34.0
64.2% (tt0)
chi angles: 189.2,170.8,156.6
0.024Å--
A 256 MET54.09-Favored (78.52%)
General case / -63.8,-34.7
9.2% (mtp)
chi angles: 273.1,157.8,98.5
0.017Å--
A 257 VAL48.35-Favored (16.83%)
Isoleucine or valine / -79.3,-51.4
72.2% (t)
chi angles: 173.8
0.116Å--
A 258 ARG63.21-Favored (57.61%)
General case / -75.4,-25.6
55.8% (mtt180)
chi angles: 288.6,203.5,185.7,155
0.059Å--
A 259 HIS51.41-Favored (9.64%)
General case / 67.5,21.4
83.9% (m-70)
chi angles: 308.1,285.5
0.179Å--
A 260 LYS110.36-Favored (30.8%)
General case / -144.5,143.3
39.9% (mtmt)
chi angles: 279.6,188.3,269.9,182
0.056Å--
A 261 ILE49.5-Favored (16.64%)
Isoleucine or valine / -54.8,130.2
60.6% (mt)
chi angles: 297.7,159.9
0.047Å--
A 262 LEU43.79-Favored (61.58%)
General case / -66.8,-50.8
17.5% (mt)
chi angles: 291.9,194
0.052Å--
A 263 PHE49.02-Favored (55.77%)
Pre-proline / -123.8,80.7
13.3% (m-85)
chi angles: 318.5,111.9
0.11Å--
A 264 PRO61.38-Allowed (1.94%)
Trans proline / -84.0,82.5
74.1% (Cg_endo)
chi angles: 28.6,337.9,126.7
0.075Å--
A 265 GLY62.2-Favored (13.08%)
Glycine / -98.5,137.1
----
A 266 ARG114.15-Favored (59.91%)
General case / -74.8,-20.1
21% (ptt180)
chi angles: 44.8,167,169.1,170.9
0.074Å--
A 267 ASP78.14-Favored (17.77%)
General case / -156.1,172.8
1.7% (p30)
chi angles: 51.4,76.7
0.032Å--
A 268 TYR66.51-Favored (76.91%)
General case / -59.5,-36.9
2.7% (m-85)
chi angles: 274.9,143.4
0.084Å--
A 269 ILE71.74-Favored (12.7%)
Isoleucine or valine / -61.9,-57.3
21.8% (mm)
chi angles: 299.4,287.7
0.051Å--
A 270 ASP74.76-Favored (82.47%)
General case / -57.1,-43.7
22.4% (t0)
chi angles: 195.2,39
0.025Å--
A 271 GLN81.04-Favored (59.55%)
General case / -54.5,-53.0
48.6% (tp60)
chi angles: 187.1,81.5,50.6
0.066Å--
A 272 TRP50.99-Favored (85.56%)
General case / -59.0,-40.6
74.6% (t-105)
chi angles: 183.1,248
0.117Å--
A 273 ASN63.43-Favored (95.83%)
General case / -62.1,-44.8
91.7% (m-20)
chi angles: 293.5,324
0.071Å--
A 274 LYS92.41-Favored (81.27%)
General case / -63.4,-35.7
37% (mmtm)
chi angles: 300.9,279,197.2,290.1
0.032Å--
A 275 VAL44.66-Favored (21.43%)
Isoleucine or valine / -65.8,-55.0
38.4% (t)
chi angles: 165.9
0.073Å--
A 276 ILE60.49-Favored (69.86%)
Isoleucine or valine / -66.2,-34.4
17.1% (pt)
chi angles: 65.1,158.9
0.235Å--
A 277 GLU84.14-Favored (73.4%)
General case / -60.5,-34.0
21.7% (mt-10)
chi angles: 275,154.4,27.9
0.073Å--
A 278 GLN63.4-Favored (5.87%)
General case / -95.6,-48.3
73.5% (mt-30)
chi angles: 290.9,181.1,60.7
0.063Å--
A 279 LEU48.23-Favored (22.07%)
General case / -92.3,-19.5
46% (mt)
chi angles: 309.6,177.7
0.069Å--
A 280 GLY50.49-Favored (35.46%)
Glycine / 95.3,166.8
----
A 281 THR58.9-Favored (91.82%)
Pre-proline / -63.7,127.7
30.1% (m)
chi angles: 307.2
0.111Å--
A 282 PRO60.42-Favored (28.02%)
Trans proline / -67.1,165.0
55.8% (Cg_endo)
chi angles: 25.7,326.5,147.3
0.033Å--
A 283 CYS62.87-Favored (7.92%)
Pre-proline / -57.2,159.5
25.2% (p)
chi angles: 67.4
0.042Å--
A 284 PRO67.32-Favored (49.63%)
Trans proline / -66.0,-28.3
17% (Cg_exo)
chi angles: 345.9,29.4,87.5
0.032Å--
A 285 GLU63.94-Favored (73.53%)
General case / -61.2,-33.5
-0.033Å--
A 286 PHE57.69-Favored (74.83%)
General case / -69.4,-42.7
85.4% (t80)
chi angles: 174.9,81.1
0.032Å--
A 287 MET69.1-Favored (80.05%)
General case / -58.0,-40.2
13.4% (mmt)
chi angles: 308.3,303.2,194.6
0.034Å--
A 288 LYS129.04-Favored (61.98%)
General case / -58.1,-26.0
60.4% (mttm)
chi angles: 286.6,186,186.9,282.7
0.057Å--
A 289 LYS85.34-Favored (51.25%)
General case / -87.4,-10.7
46.9% (mtmt)
chi angles: 297.8,189.5,276.8,173.8
0.077Å--
A 290 LEU69.15-Favored (29.47%)
General case / -80.9,149.5
32.3% (mt)
chi angles: 290.3,159.3
0.021Å--
A 291 GLN118.330.421Å
HE21 with A 292 PRO HD2
Favored (95.76%)
Pre-proline / -62.0,140.7
0.1%
chi angles: 211.9,241.2,274.1
0.06Å--
A 292 PRO80.210.421Å
HD2 with A 291 GLN HE21
Favored (9.44%)
Trans proline / -43.0,-44.7
85.3% (Cg_exo)
chi angles: 331.7,30.6,100.1
0.067Å--
A 293 THR80.52-Favored (69.6%)
General case / -66.3,-48.6
72.3% (p)
chi angles: 63.4
0.144Å--
A 294 VAL63.74-Favored (98.13%)
Isoleucine or valine / -62.9,-42.9
11% (t)
chi angles: 192.2
0.163Å--
A 295 ARG116.95-Favored (81.03%)
General case / -56.7,-46.8
67.6% (ttt180)
chi angles: 188.8,180.7,184.1,166.5
0.059Å--
A 296 ASN102.25-Favored (91.8%)
General case / -60.3,-45.9
25.2% (t-20)
chi angles: 180.7,275.1
0.033Å--
A 297 TYR78.92-Favored (92.47%)
General case / -63.6,-45.0
81.7% (t80)
chi angles: 172.9,76.3
0.072Å--
A 298 VAL68.09-Favored (81.27%)
Isoleucine or valine / -69.3,-43.4
68.4% (t)
chi angles: 171.6
0.176Å--
A 299 GLU108.11-Favored (62.97%)
General case / -70.2,-23.3
29% (mt-10)
chi angles: 267.7,180.6,4.4
0.056Å--
A 300 ASN98.24-Favored (48.3%)
General case / -98.0,5.8
10.4% (m120)
chi angles: 279.4,91.4
0.133Å--
A 301 ARG117.820.431Å
HA with A 301 ARG HD2
Favored (82.79%)
Pre-proline / -76.6,156.9
0%
chi angles: 238.7,30.6,190.9,96.3
0.041Å--
A 302 PRO78.46-Favored (20.93%)
Trans proline / -62.5,127.5
19.8% (Cg_exo)
chi angles: 344.9,29.9,87.8
0.045Å--
A 303 LYS113.04-Favored (48.83%)
General case / -69.9,148.6
9.2% (mptt)
chi angles: 280.9,90.9,188.6,176.3
0.096Å--
A 304 TYR86.1-Favored (23.9%)
General case / -141.1,130.6
57.7% (m-85)
chi angles: 284.7,101.5
0.026Å--
A 305 ALA58.66-Favored (68.38%)
General case / -68.6,-29.8
-0.045Å--
A 306 GLY56.88-Favored (37.84%)
Glycine / 86.5,163.0
----
A 307 LEU63.41-Favored (24.57%)
General case / -97.8,147.3
7% (mp)
chi angles: 275.2,48.2
0.069Å--
A 308 THR55.22-Favored (37.04%)
General case / -74.2,156.7
26.6% (p)
chi angles: 71.4
0.032Å--
A 309 PHE52.89-Favored (20.68%)
Pre-proline / -64.4,-36.9
30.1% (m-85)
chi angles: 276.6,84
0.206Å--
A 310 PRO58.03-Favored (94.97%)
Trans proline / -60.0,-34.0
42.9% (Cg_exo)
chi angles: 337.6,35.2,86.3
0.029Å--
A 311 LYS109-Favored (63.24%)
General case / -72.9,-42.7
22.1% (mttp)
chi angles: 258.3,175.9,168.3,69.2
0.049Å--
A 312 LEU61.74-Favored (92.53%)
General case / -62.4,-45.6
33.6% (mt)
chi angles: 286.8,159.9
0.021Å--
A 313 PHE54.53-Favored (45.81%)
Pre-proline / -122.6,76.2
76.5% (m-85)
chi angles: 304.6,99.4
0.052Å--
A 314 PRO61.5-Favored (22.55%)
Trans proline / -61.3,161.7
31.5% (Cg_exo)
chi angles: 339.2,35,84.9
0.068Å--
A 315 ASP84.98-Favored (39.87%)
General case / -51.2,-36.2
79.7% (m-20)
chi angles: 297.8,155.5
0.024Å--
A 316 SER80.75-Favored (33.57%)
General case / -49.2,-40.3
2.2% (m)
chi angles: 319.3
0.045Å--
A 317 LEU62.12-Favored (62.36%)
General case / -71.4,-18.1
91.6% (mt)
chi angles: 299.2,178.7
0.075Å--
A 318 PHE70.880.425Å
C with A 320 ALA H
Favored (39.92%)
Pre-proline / -112.2,97.6
96.2% (m-85)
chi angles: 298.6,94.2
0.032Å--
A 319 PRO78.05-Allowed (0.21%)
Trans proline / -70.9,28.7
10.4% (Cg_exo)
chi angles: 349.8,29.5,83.5
0.084Å--
A 320 ALA75.780.425Å
H with A 318 PHE C
OUTLIER (0%)
General case / -39.6,85.6
-0.052Å--
A 321 ASP91.16-Allowed (1.24%)
General case / -81.7,-64.2
2.7% (p-10)
chi angles: 43.6,124.2
0.103Å--
A 322 SER61.44-Favored (14.97%)
General case / -76.2,171.2
53.8% (p)
chi angles: 74.1
0.018Å--
A 323 GLU58.01-Favored (80.41%)
General case / -68.8,-39.2
61.6% (mm-40)
chi angles: 287.8,290.9,172.7
0.036Å--
A 324 HIS58.42-Favored (60.98%)
General case / -52.7,-51.3
57.6% (t60)
chi angles: 170.8,89.6
0.023Å--
A 325 ASN60.97-Favored (79.71%)
General case / -66.6,-35.2
87.3% (m-20)
chi angles: 282,342.9
0.109Å--
A 326 LYS60.35-Favored (95.73%)
General case / -62.9,-44.6
76% (mttt)
chi angles: 280.8,182.7,170.1,160.8
0.024Å--
A 327 LEU50.37-Favored (73.13%)
General case / -68.8,-44.8
43.1% (tp)
chi angles: 181.8,55.9
0.055Å--
A 328 LYS74.72-Favored (80.81%)
General case / -62.9,-35.7
16% (mmtt)
chi angles: 291.1,278.7,141,203.7
0.069Å--
A 329 ALA41.49-Favored (94.77%)
General case / -64.0,-43.7
-0.042Å--
A 330 SER52.28-Favored (97.55%)
General case / -60.8,-43.8
10.1% (t)
chi angles: 164.2
0.031Å--
A 331 GLN50.41-Favored (77.91%)
General case / -69.3,-37.4
95.6% (mt-30)
chi angles: 294.3,173.4,342.2
0.064Å--
A 332 ALA39.37-Favored (89.31%)
General case / -63.5,-45.7
-0.052Å--
A 333 ARG91.68-Favored (90.74%)
General case / -65.4,-38.7
21.8% (ttm105)
chi angles: 195.1,197.2,279.7,107.6
0.106Å--
A 334 ASP49.56-Favored (99.51%)
General case / -61.2,-43.0
37% (t70)
chi angles: 183.4,67.9
0.031Å--
A 335 LEU39-Favored (84.48%)
General case / -67.1,-42.5
63% (tp)
chi angles: 179.6,61.3
0.108Å--
A 336 LEU42.73-Favored (84.09%)
General case / -57.2,-44.9
9.2% (mt)
chi angles: 267.1,168.2
0.066Å--
A 337 SER39.05-Favored (63.9%)
General case / -59.3,-25.2
13.2% (p)
chi angles: 82.4
0.086Å--
A 338 LYS52.84-Favored (18.08%)
General case / -93.6,-24.1
59.2% (mttm)
chi angles: 292.1,175.7,188.1,311.7
0.053Å--
A 339 MET39.01-Favored (13.6%)
General case / -89.7,-38.8
67.1% (mtm)
chi angles: 299.6,197,292.9
0.032Å--
A 340 LEU38.37-Favored (5.86%)
General case / -88.3,60.7
61.3% (mt)
chi angles: 285.3,169.9
0.052Å--
A 341 VAL40.91-Favored (65.91%)
Isoleucine or valine / -115.7,120.8
91.8% (t)
chi angles: 177
0.071Å--
A 342 ILE43.11-Favored (85.25%)
Isoleucine or valine / -58.8,-48.7
62.6% (mt)
chi angles: 296.3,160.1
0.148Å--
A 343 ASP61.44-Favored (31.32%)
Pre-proline / -75.3,114.0
55.1% (t0)
chi angles: 190.9,176.6
0.07Å--
A 344 PRO47.77-Favored (74.04%)
Trans proline / -62.9,-22.8
18.7% (Cg_endo)
chi angles: 18,333,144.8
0.069Å--
A 345 ALA52.52-Favored (65.43%)
General case / -67.5,-22.4
-0.02Å--
A 346 LYS86.36-Favored (15.04%)
General case / -112.8,-0.0
24.5% (mtmm)
chi angles: 290.2,186.3,266.9,289.6
0.034Å--
A 347 ARG44.47-Favored (28.99%)
General case / -86.9,141.1
35% (ttm180)
chi angles: 192.8,184.9,303,148.9
0.09Å--
A 348 ILE52.12-Favored (10.15%)
Isoleucine or valine / -59.6,146.3
12% (tt)
chi angles: 200,174.9
0.138Å--
A 349 SER44.79-Favored (12.92%)
General case / -84.2,171.3
99.4% (p)
chi angles: 64.5
0.071Å--
A 350 VAL39.170.498Å
HA with A 246 ILE HD11
Favored (99.26%)
Isoleucine or valine / -63.3,-44.8
54.8% (t)
chi angles: 169.9
0.144Å--
A 351 ASP58.63-Favored (96.18%)
General case / -61.1,-41.2
92.6% (m-20)
chi angles: 285,168.6
0.077Å--
A 352 ASP53.67-Favored (65.5%)
General case / -73.6,-36.5
87.3% (m-20)
chi angles: 294.8,156.5
0.134Å--
A 353 ALA40.04-Favored (80.34%)
General case / -61.3,-36.5
-0.018Å--
A 354 LEU44.27-Favored (61.98%)
General case / -71.4,-23.9
18.7% (mt)
chi angles: 282.8,157.5
0.032Å--
A 355 GLN93.26-Favored (49.51%)
General case / -91.7,-7.5
13.9% (mm100)
chi angles: 289.4,275,67.9
0.035Å--
A 356 HIS43.2-Favored (96.17%)
Pre-proline / -66.2,138.7
65.5% (t-80)
chi angles: 189.8,280.4
0.035Å--
A 357 PRO49.68-Favored (69.7%)
Trans proline / -52.5,-36.3
74.7% (Cg_exo)
chi angles: 333.7,35.2,90.7
0.053Å--
A 358 TYR42.46-Favored (75.34%)
General case / -60.0,-35.6
30.5% (t80)
chi angles: 195,67.8
0.047Å--
A 359 ILE44.95-Favored (11.29%)
Isoleucine or valine / -96.3,-41.0
48.5% (mm)
chi angles: 304.1,302.9
0.084Å--
A 360 ASN86.99-Allowed (0.92%)
General case / -45.1,-29.4
6.3% (t-20)
chi angles: 216.3,7.5
0.03Å--
A 361 VAL52.87-Favored (28.78%)
Isoleucine or valine / -62.2,-22.3
14.1% (m)
chi angles: 306.4
0.168Å--
A 362 TRP51.7-Favored (21.16%)
General case / -97.0,-15.3
81.2% (m95)
chi angles: 302.9,110.3
0.016Å--
A 363 TYR63.05-Allowed (0.82%)
General case / -41.7,116.7
14.9% (t80)
chi angles: 200.6,96.1
0.128Å--
A 364 ASP66.15-Favored (13.17%)
Pre-proline / -134.8,118.1
64.8% (t0)
chi angles: 180.1,177.7
0.039Å--
A 365 PRO72.36-Favored (81.81%)
Trans proline / -56.7,-29.9
52.2% (Cg_exo)
chi angles: 336.6,36.5,85.3
0.053Å--
A 366 ALA64.17-Favored (66.65%)
General case / -67.5,-27.0
-0.024Å--
A 367 GLU77.42-Favored (11.61%)
General case / -93.5,-38.1
65.5% (mt-10)
chi angles: 303.8,167.7,148.4
0.012Å--
A 368 VAL62.88-Favored (16.11%)
Isoleucine or valine / -83.0,-40.2
91.9% (t)
chi angles: 178
0.095Å--
A 369 GLU103.91-Favored (3.49%)
General case / -110.1,35.2
14.9% (mt-10)
chi angles: 297.4,152.1,62
0.056Å--
A 370 ALA78.48-Favored (88.74%)
Pre-proline / -61.2,146.2
-0.037Å--
A 371 PRO90.37-Favored (34.9%)
Trans proline / -56.9,129.5
49% (Cg_exo)
chi angles: 337,35.7,86.2
0.054Å--
A 372 PRO94.49-Favored (3.96%)
Trans proline / -78.6,117.3
2.3% (Cg_endo)
chi angles: 0.9,18.2,90.4
0.02Å--
A 373 PRO93.630.456Å
HG2 with A 118 VAL HA
Favored (14.57%)
Trans proline / -80.6,142.5
4% (Cg_exo)
chi angles: 359.2,21.9,86.1
0.051Å--
A 374 GLN136.15---0.041Å--
A 379 GLN111.66---0.05Å--
A 380 LEU113.04-Favored (6.78%)
General case / -130.8,103.8
2.7% (mp)
chi angles: 308.4,101.1
0.032Å--
A 381 ASP114.15-Favored (22.71%)
General case / -164.1,162.0
21.3% (t0)
chi angles: 198.5,34.6
0.035Å--
A 382 GLU100.26-OUTLIER (0.03%)
General case / 51.9,87.6
-0.104Å--
A 383 ARG93.93-Favored (3.74%)
General case / -163.8,132.5
-0.037Å--
A 384 GLU113.07-Favored (37.57%)
General case / -78.3,135.8
5.2% (pt-20)
chi angles: 61.4,159,95.8
0.078Å--
A 385 HIS77.7-Favored (46.79%)
General case / -140.2,154.1
92.2% (m-70)
chi angles: 290.3,288.2
0.061Å--
A 386 THR75.27-Favored (12.84%)
General case / -80.9,173.2
44.6% (p)
chi angles: 55
0.048Å--
A 387 ILE63.58-Favored (64.69%)
Isoleucine or valine / -55.6,-50.8
91.1% (mt)
chi angles: 294.6,166.4
0.06Å--
A 388 GLU85.72-Favored (83.03%)
General case / -57.5,-47.0
0%
chi angles: 24.4,151.7,68.4
0.118Å--
A 389 GLU75.64-Favored (85.9%)
General case / -65.1,-45.2
80.6% (mt-10)
chi angles: 294.2,161.4,161.1
0.022Å--
A 390 TRP48.36-Favored (95.01%)
General case / -60.9,-40.9
8.8% (m95)
chi angles: 279.1,129.9
0.025Å--
A 391 LYS76.66-Favored (81.51%)
General case / -57.3,-47.5
80.5% (tttt)
chi angles: 189,174.3,185.4,190.8
0.034Å--
A 392 GLU85.72-Favored (76.96%)
General case / -69.7,-39.6
20.1% (tt0)
chi angles: 203.6,174.4,90.8
0.089Å--
A 393 LEU61.07-Favored (96.79%)
General case / -64.1,-42.9
31.5% (mt)
chi angles: 287.4,159.2
0.075Å--
A 394 ILE52.33-Favored (79.54%)
Isoleucine or valine / -68.6,-46.7
67.4% (mt)
chi angles: 293.2,160.9
0.154Å--
A 395 TYR61.64-Favored (86.71%)
General case / -58.0,-43.3
71.8% (t80)
chi angles: 184.7,70.5
0.028Å--
A 396 LYS113.18-Favored (93.56%)
General case / -64.5,-39.3
84.5% (mttt)
chi angles: 278.4,169.3,181.3,174.4
0.064Å--
A 397 GLU81.73-Favored (93.21%)
General case / -65.5,-40.6
5.7% (tp10)
chi angles: 207.8,46.7,61.3
0.044Å--
A 398 VAL59.13-Favored (83.24%)
Isoleucine or valine / -67.9,-45.8
54.1% (t)
chi angles: 170.1
0.131Å--
A 399 MET72.65-Favored (61.1%)
General case / -74.2,-28.1
33.6% (mmt)
chi angles: 296.2,290.5,93.4
0.084Å--
A 400 ASN126.65--1.3% (m-20)
chi angles: 241.3,334.6
0.116Å--
A 502 ANP56.14------
A 501 88044.82------
A 601 HOH35.16------
A 602 HOH30.06------
A 603 HOH40.95------
A 604 HOH39.14------
A 605 HOH46.44------
A 606 HOH33.91------
A 607 HOH38.53------
A 608 HOH37.71------
A 609 HOH44.79------
A 610 HOH38.49------
A 611 HOH43.86------
A 612 HOH46.69------
A 613 HOH33.69------
A 614 HOH43.5------
A 615 HOH35.73------
A 616 HOH40.55------
A 617 HOH51.23------
A 619 HOH42.8------
A 621 HOH52------
A 622 HOH48.07------
A 623 HOH51.05------
A 624 HOH57.03------
A 625 HOH38.17------
A 626 HOH60.09------
A 627 HOH42.26------
A 628 HOH56.13------
A 629 HOH41.92------
A 631 HOH43.21------
A 632 HOH44.27------
A 633 HOH61.77------
A 634 HOH51.16------
A 639 HOH39.54------
A 640 HOH53.2------
A 641 HOH49.31------
A 642 HOH54.76------
A 646 HOH54.75------
A 647 HOH45.19------
A 648 HOH50.42------
A 649 HOH57.11------
A 651 HOH47.32------
A 654 HOH48.4------
A 655 HOH47.46------
A 656 HOH45.62------
A 658 HOH59------
A 659 HOH70.67------
A 663 HOH57.14------
A 664 HOH59.82------
A 665 HOH51.69------
A 669 HOH68.02------
A 671 HOH45.91------
A 677 HOH49.59------
A 680 HOH49.25------
A 681 HOH51.26------
A 682 HOH69.95------